CORRECTING and REPLACING SonoSite Introduces Major Software Breakthrough for Visualizing Deep Needle Insertions at Steep Angles
July 13 2010 - 3:48PM
Business Wire
Seventh graph, first sentence of release should read: “We are
elated by the response so far by physician users..." (sted “We are
elated by the response so far by position users...").
The corrected release reads:
SONOSITE INTRODUCES MAJOR SOFTWARE
BREAKTHROUGH FOR VISUALIZING DEEP NEEDLE INSERTIONS AT STEEP
ANGLES
Major Advancement for Regional
Nerve Blocks and Other Injection Based Procedures
Highly Advanced Algorithms Were
Developed Over Two Years and Aimed at Solving the Disappearing
Needle Phenomenon in Anesthesia
SonoSite, Inc. (Nasdaq:SONO), the world leader and
specialist in bedside and point-of-care ultrasound, today
introduced Enhanced Needle Visualization, a significant development
in ultrasound imaging that enables improved needle tracking with
increased confidence during deep needle procedures. Enhanced Needle
Visualization is a proprietary imaging technology that intensifies
the brightness of the needle, making it clearly visible during a
steep angle approach to a deep target, conditions under which the
needle has previously been difficult to image. Enhanced Needle
Visualization is now available as a software upgrade for SonoSite’s
M-Turbo® and S Series™ ultrasound product lines.
SonoSite’s Enhanced Needle Visualization technology is the first
fully-integrated solution to resolve the “lost needle phenomenon,”
1 which has been an accepted constraint for needle-guidance since
the creation of ultrasound imaging. Developed over the last two
years, SonoSite’s engineers collaborated with physicians worldwide
and challenged the conventional principles of ultrasound system
design to break new grounds for needle visibility. As a result, the
revolutionary Enhanced Needle Visualization technology was
introduced for SonoSite ultrasound systems.
“Enhanced Needle Visualization is a unique, proprietary
technology that cannot be found in any other ultrasound product,
including large cart-based systems,” said Jim Gilmore, SonoSite’s
Senior Vice President of Product Innovation and Delivery. “This
technology adaptively enhances the ultrasound visualization of
needles at steep angles without compromising tissue image
quality.”
Enhanced Needle Visualization is fully-integrated into the
architecture of SonoSite’s systems and can be operated with a
simple on/off button, enabling physicians to potentially decrease
procedure time and considerably reduce costs per procedure.
“With clear needle visibility at deep and steep angles,
SonoSite’s Enhanced Needle Visualization allows me to more
confidently perform a nerve block and provide better medicine to my
patients,” said David Auyong, MD, Staff Anesthesiologist, Seattle,
Washington. “This streamlined technology can also be activated at
the touch of a button, which allows me to operate more efficiently
and ultimately save money. When I am performing a nerve block, I
want to be able to turn on the ultrasound system, place the
transducer and insert the needle. With Enhanced Needle
Visualization, I will not need to spend an extra five to ten
minutes setting up additional equipment or finding echogenic
needles, which streamlines my practice.”
“SonoSite’s Enhanced Needle Visualization technology is
extremely impressive,” said Mimi Lee, MD, Anesthesiology
Consultants of Marin, located in California. “This is going to
eliminate any difficulties I have with accurately visualizing the
shaft of the needle and it will decrease the time it takes to
perform a steep needle procedure. This is also an excellent
teaching tool for residents who are relatively unfamiliar with
ultrasound and the different techniques; I think they will pick up
the technology immediately.”
“We are elated by the response so far by physician users in the
marketplace for this breakthrough in point-of-care visualization,”
said Kevin M. Goodwin, SonoSite’s President and CEO. “This is a
major advancement in needle guidance for medicine. We have received
an overwhelmingly positive response from physicians around the
world who have had the opportunity to assess Enhanced Needle
Visualization. Physicians have commented that this technology will
become the new industry standard for needle visualization. Enhanced
Needle Visualization has already helped us to win a number of
orders in the competitive market environment and we are
anticipating strong product demand.”
Enhanced Needle Visualization supports SonoSite’s continuous
efforts to provide physicians with innovative solutions to improve
patient safety. This breakthrough technology is currently offered
on SonoSite’s HFL50 and HFL38 transducers for peripheral nerve
block applications. SonoSite expects to expand applications for
Enhanced Needle Visualization technology to a broad range of
point-of-care specialties, including breast surgeons,
musculoskeletal specialists, endocrinologists, interventional
radiologists and emergency medicine physicians. SonoSite has
applied for patent protection for this significant advance in
needle visualization technology.
About SonoSite
SonoSite, Inc. (www.sonosite.com) is the innovator and world
leader in bedside and point-of-care ultrasound and an industry
leader in ultra high-frequency micro-ultrasound technology and
impedance cardiography equipment. Headquartered near Seattle, the
company is represented by ten subsidiaries and a global
distribution network in over 100 countries. SonoSite’s small,
lightweight systems are expanding the use of ultrasound across the
clinical spectrum by cost-effectively bringing high-performance
ultrasound to the point of patient care.
Forward-looking Information
and the Private Litigation Reform Act of 1995
Certain statements in this press release relating to the
expected benefits of Enhanced Needle Visualization technology,
including market acceptance of products incorporating Enhanced
Needle Visualization technology and new market and sales
opportunities for SonoSite, and other statements regarding future
results are “forward-looking statements” for the purposes of the
safe harbor provisions of the Private Securities Litigation Reform
Act of 1995. These forward-looking statements are based on the
opinions and estimates of our management at the time the statements
are made and are subject to risks and uncertainties that could
cause actual results to differ materially from those expected or
implied by the forward-looking statements. These statements are not
guaranties of future performance and are subject to known and
unknown risks and uncertainties and are based on potentially
inaccurate assumptions. Factors that could cause actual results to
differ from the forward-looking statements include: the risk that
the technology will not yield the expected potential benefits,
including the risk that we are unsuccessful in achieving market
acceptance of this technology, and the potential
for competitive technologies, as well as other factors
contained in the Item 1A. “Risk Factors” section of our most recent
Annual Report on Form 10-K filed with the Securities and Exchange
Commission. We caution readers not to place undue reliance upon
these forward-looking statements that speak only as to the date of
this release. We undertake no obligation to publicly revise any
forward-looking statements to reflect new information, events or
circumstances after the date of this release or to reflect the
occurrence of unanticipated even.
1 Miller, Gabriel. "Study Ranks Needle Visibility Under
Ultrasound." Pain Medicine News. Mar. 2010. Web. .
Photos/Multimedia Gallery Available:
http://www.businesswire.com/cgi-bin/mmg.cgi?eid=6358462&lang=en
Sonos (NASDAQ:SONO)
Historical Stock Chart
From Jun 2024 to Jul 2024
Sonos (NASDAQ:SONO)
Historical Stock Chart
From Jul 2023 to Jul 2024